HLA-E and breast carcinoma: Interestingly, after applying more strict statistical testing on the differential expression of HLA genes, whereby we adjusted the P-values with Bonferroni multiple correction and performed filtering based on fold change, HLA-E maintained a significant downregulation in both breast cancer subtypes compared to their normal tissue counterparts (Supplementary Tables S2 and S4, Supplementary Figure S2).